Analogic reaffirms FY13 total company single-digit revenue growth outlook The company said, "At the beginning of March, we completed the acquisition of Ultrasonix Medical, complementing our already strong Ultrasound product portfolio and sales channel, and accelerating penetration into the point-of-care market. We reaffirm our total company outlook for the year of upper single-digit revenue growth organically, and combined with the acquisition of Ultrasonix, we are targeting 10% revenue growth this fiscal year over last year. We also expect to improve annual non-GAAP operating margins by 100 basis points on a total company basis."
Analogic upgraded to Buy from Hold at Brean Capital Brean Capital upgraded Analogic to Buy with a $110 price target saying it expects the business to both uptick and be more predictable going into FY16. Brean sees the company's growth being led by ultrasound.